Skip to content
Wenlo
Sign in
← Markets

Lexeo Therapeutics, Inc.

Tobin Schilke (Director) reports LXEO insider transactions

4LXEOFiled Nov 17, 2026, 12:56 PM ET· Period Nov 14, 2026

About this filing

Lexeo Therapeutics, Inc. (LXEO) filed Form 4 (insider transaction) with the SEC on Nov 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Tobin Schilke · Director
DateTransactionSharesPriceValueHeld afterOwnership
Nov 14, 2026A · grantStock Option (right to buy)Footnotes F1+70,000$0.00$0.0070,000Direct
Footnotes
  1. F1 1/3rd of the shares underlying the option shall vest, and become exercisable, on each yearly anniversary of the Grant Date, such that all shares are vested and exercisable on November 14, 2029, subject to the Reporting Person's continuous service on each such vesting date.

More LXEO filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.